# Proteinea: Biotechnology, Cambridge, United States

> Proteinea: Proteinea is a TechBio startup based in Cairo, Egypt, that focuses on the discovery, engineering, and manufacturing of biotherapeutics.

Source: https://millionrounds.com/startup/proteinea (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Proteinea

Proteinea is a TechBio startup based in Cairo, Egypt, that focuses on the discovery, engineering, and manufacturing of biotherapeutics.

Email

Funding reported Last round: Seed

Biotechnology Cambridge, United States

Follow Proteinea and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fproteinea)

Company summary

- **Founded:** 2020 6 years old
- **Team:** 51 51 to 200 people
- **Funding reported:** $4.7M in dollars
- **Last round:** Seed Aug 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Proteinea has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Proteinea

Proteinea is a TechBio startup based in Cairo, Egypt, that focuses on the discovery, engineering, and manufacturing of biotherapeutics.

Founded in 2020, the company integrates artificial intelligence with biotechnology to enhance the development of life-saving therapies. Proteinea has established a presence in key innovation hubs, including Cambridge and Boston in the USA, and Thuwal in Saudi Arabia. The company offers a range of services in the B2B Life Sciences market, including AI-driven protein engineering, therapeutic protein production, and innovative biomanufacturing using mass-reared insect larvae. Proteinea's proprietary technologies, such as the Ankh protein language model and its insect larvae biomanufacturing system, enable efficient and sustainable production of various proteins, including antibiotics and vaccines. With a strong focus on collaboration, Proteinea partners with pharmaceutical companies, biotech firms, and academic institutions to advance drug discovery and development processes.

## What company datasets say Proteinea raised

Funding, as reported

Reported in all **$4.7M** in dollars

Last round **Seed**

Last round date **Aug 2023**

Investors listed **5**

## On 4 portfolio pages

Investors who name them

- [VentureSouq](https://millionrounds.com/fund/venturesouq)
- [Sawari Ventures](https://millionrounds.com/fund/sawari-ventures)
- [A4AVC](https://millionrounds.com/fund/a4avc)
- [Kerna Ventures](https://millionrounds.com/fund/kerna-ventures)

Each firm lists Proteinea on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care insect larvae platform protein generation analysis biotechnology solutions molecular modeling protein thermal stability manufacturing protein functionality biotech safety improvements cell therapy therapeutic proteins structural biology protein expression in heterologous systems information technology & services cost-efficient bioproduction antibody optimization

Built with from their website

Docker Google Tag Manager Amazon CloudFront Google Workspace CloudFlare Viewport Meta Webflow Hosting AI Google Meet CloudFlare CDN

+8 more

React Mobile Friendly Open Graph jQuery Anthropic Claude Cloudflare DNS Google Analytics HTTP/3

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714, SIC 8731
- **Region:** Massachusetts

## Biotechnology in United States

Startups like it

- [**National Resilience** founded 2020 *Raised*](https://millionrounds.com/company/national-resilience)
- [**CREATE Medicines** Cambridge · founded 2019 *Raised*](https://millionrounds.com/company/create-medicines)
- [**AusperBio Therapeutics** Startup *Raised*](https://millionrounds.com/company/ausperbio-therapeutics)
- [**City Therapeutics** Startup *Raised*](https://millionrounds.com/company/city-therapeutics)
- [**Nohla Therapeutics** Seattle · founded 2015 *Raised*](https://millionrounds.com/company/nohla-therapeutics)
- [**Genapsys** Redwood City · founded 2010 *Raised*](https://millionrounds.com/company/genapsys)
- [**Proxima Bio** Startup *Raised*](https://millionrounds.com/company/proxima-bio)
- [**Infinimmune** Alameda · founded 2022 *Raised*](https://millionrounds.com/company/infinimmune)

## Is this your company?

Add your raise, your deck and your story, and put Proteinea in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)